These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37441211)

  • 21. Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu T; Shah D; Bailey P; Dewey HM; Choi PMC; Ma A; Wijeratne T; Garcia-Esperon C; Cloud G; Chandra RV; Cordato DJ; Yan B; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2023 May; 100(18):e1900-e1911. PubMed ID: 36878701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
    Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis - A retrospective cohort analysis.
    Sjögren V; Ekici R; Faergemann E; Björck F
    IBRO Neurosci Rep; 2023 Jun; 14():353-357. PubMed ID: 37063607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clot migration in patients treated with tenecteplase versus alteplase before mechanical thrombectomy.
    García-Alcántara G; Moreno-López C; López-Rebolledo R; Lorenzo-Barreto P; Garay-Albízuri P; Martínez-García B; Llanes A; Pérez-Gil D; Chico JL; Vera-Lechuga R; García-Madrona S; Matute-Lozano C; De Felipe-Mimbrera A; Masjuan J; Cruz-Culebras A
    Eur Stroke J; 2024 Jun; ():23969873241263201. PubMed ID: 38915244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry.
    Rodriguez N; Prasad S; Olson DM; Bandela S; Gealogo Brown G; Kwon Y; Gebreyohanns M; Jones EM; Ifejika NL; Stone S; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Goldberg MP; Birnbaum LA
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107774. PubMed ID: 38795796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design.
    Zhao ZA; Qiu J; Li W; Nguyen T; Wang S; Shi H; Wei M; Wang F; Li D; Chen HS
    Stroke Vasc Neurol; 2024 Feb; 9(1):59-65. PubMed ID: 37169399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenecteplase versus Alteplase before thrombectomy: A comprehensive evaluation of clinical and angiographic impact: Insights from the ETIS registry.
    Zarzour A; Batot C; Boisseau W; Cho TH; Guillon B; Richard S; Marnat G; Arquizan C; Lapergue B; Weisenburger Lile D;
    J Neuroradiol; 2024 Jun; 51(4):101189. PubMed ID: 38462131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke.
    Alhadid K; Oliveira L; Etherton MR
    Curr Treat Options Cardiovasc Med; 2023; 25(1):15-28. PubMed ID: 36618509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-Term Efficacy Outcomes of Tenecteplase versus Alteplase for Acute Ischemic Stroke: A Meta-Analysis of 5 Randomized Trials.
    Requiao LE; Oliveira RS; Reis LS; B Assis AP; G Moreno BN; Cordeiro LR; Solla DF
    Neurol India; 2022; 70(4):1454-1459. PubMed ID: 36076643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J; Waters MJ; Drew R; Fink JN; Wilson D; Campbell BCV; Parsons MW; Kleinig TJ; Wu TY
    Stroke; 2020 May; 51(5):1616-1619. PubMed ID: 32208845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase.
    Ezzeldin M; Hill C; Kerro A; Percenti E; Delora A; Santos J; Saei H; Greco L; Ezzeldin R; El-Ghanem M; Alderazi Y; Kim Y; Poitevint C; Mir O
    Cureus; 2023 Oct; 15(10):e46889. PubMed ID: 37859677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Systematic Review and Meta-analysis.
    Singh A; Singh MP; Gaikwad NR; Kannauje PK
    Ann Neurosci; 2024 Apr; 31(2):132-142. PubMed ID: 38694719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
    Walton MN; Hamilton LA; Salyer S; Wiseman BF; Forster AM; Rowe AS
    Ann Pharmacother; 2023 May; 57(5):535-543. PubMed ID: 36004394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data.
    Platko S; Bensabeur F; Peters D; Darwich N; Rotsching N; Wagner J; Ugur U; Reynolds S; Terry JB; Cheng-Ching E
    J Clin Neurosci; 2024 Jun; 126():143-147. PubMed ID: 38879957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-arterial tenecteplase for treatment of acute ischemic stroke: feasibility and comparative outcomes.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Tariq NA; Suri MF; Taylor RA; Qureshi AI
    J Neuroimaging; 2012 Jul; 22(3):249-54. PubMed ID: 21883621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.